Pentafuhalol-B, a Phlorotannin from Brown Algae, Strongly Inhibits the PLK-1 Overexpression in Cancer Cells as Revealed by Computational Analysis

Polo-like kinase-1 (PLK-1) is an essential mitotic serine/threonine (Ser/Thr) kinase that belongs to the Polo-like kinase (PLK) family and is overexpressed in non-small cell lung cancer (NSCLC) via promotion of cell division. Therefore, PLK-1 may act as a promising target for the therapeutic cure of various cancers. Although a variety of anti-cancer drugs, both synthetic and naturally occurring, such as volasertib, onvansertib, thymoquinone, and quercetin, are available either alone or in combination with other therapies, they have limited efficacy, especially in the advanced stages of cancer. To the best of our knowledge, no anticancer agent has been reported from marine algae or microorganisms to date. Thus, the aim of the present study is a high-throughput virtual screening of phlorotannins, obtained from edible brown algae, using molecular docking and molecular dynamic simulation analysis. Among these, Pentafuhalol-B (PtB) showed the lowest binding energy (best of triplicate runs) against the target protein PLK-1 as compared to the reference drug volasertib. Further, in MD simulation (best of triplicate runs), the PtB-PLK-1 complex displayed stability in an implicit water system through the formation of strong molecular interactions. Additionally, MMGBSA calculation (best of triplicate runs) was also performed to validate the PtB-PLK-1 complex binding affinities and stability. Moreover, the chemical reactivity of PtB towards the PLK-1 target was also optimised using density functional theory (DFT) calculations, which exhibited a lower HOMO-LUMO energy gap. Overall, these studies suggest that PtB binds strongly within the pocket sites of PLK-1 through the formation of a stable complex, and also shows higher chemical reactivity than the reference drug volasertib. The present study demonstrated the inhibitory nature of PtB against the PLK-1 protein, establishing its potential usefulness as a small molecule inhibitor for the treatment of different types of cancer.

[1]  A. Kadi,et al.  Exploring the Chemical Reactivity, Molecular Docking, Molecular Dynamic Simulation and ADMET Properties of a Tetrahydrothienopyridine Derivative Using Computational Methods , 2023, Crystals.

[2]  G. Rocha,et al.  Quantum chemical descriptors based on semiempirical methods for large biomolecules. , 2023, The Journal of chemical physics.

[3]  A. Al-Khedhairy,et al.  Drug repositioning to discover novel ornithine decarboxylase inhibitors against visceral leishmaniasis , 2023, Journal of molecular recognition : JMR.

[4]  S. Singh,et al.  Structure-Based Virtual Screening, Molecular Docking, Molecular Dynamics Simulation of EGFR for the Clinical Treatment of Glioblastoma , 2023, Applied Biochemistry and Biotechnology.

[5]  J. Kalous,et al.  Multiple Roles of PLK1 in Mitosis and Meiosis , 2023, Cells.

[6]  I. Bakunina,et al.  marine drugs , 2022 .

[7]  M. Saquib,et al.  Computational Screening of Plant-Derived Natural Products against SARS-CoV-2 Variants , 2022, Future Pharmacology.

[8]  Y. Hamam,et al.  Application of DFT Calculations in Designing Polymer-Based Drug Delivery Systems: An Overview , 2022, Pharmaceutics.

[9]  Zaw Ali Khan,et al.  Computational Study Reveals the Inhibitory Effects of Chemical Constituents from Azadirachta Indica (Indian Neem) against Delta and Omicron Variants of SARS-CoV-2 , 2022, Coronaviruses.

[10]  Y. Akhter,et al.  Drug Repurposing to Discover Novel Anti-Inflammatory Agents Inhibiting JAK3/STAT Signaling , 2022, Russian Journal of Bioorganic Chemistry.

[11]  Subham Das,et al.  Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3Kα against non-small cell lung cancer: a computational study , 2022, RSC advances.

[12]  Zaw Ali Khan,et al.  Bioactive components of different nasal spray solutions may defeat SARS-Cov2: repurposing and in silico studies , 2022, Journal of Molecular Modeling.

[13]  Arabinda Ghosh,et al.  Target Specific Inhibition of Protein Tyrosine Kinase in Conjunction With Cancer and SARS-COV-2 by Olive Nutraceuticals , 2022, Frontiers in Pharmacology.

[14]  P. Varalakshmi,et al.  Probing marine brown macroalgal phlorotannins as antiviral candidate against SARS-CoV-2: molecular docking and dynamics simulation approach , 2022, Molecular Diversity.

[15]  Zaw Ali Khan,et al.  Exploration of Luteolin as Potential Anti-COVID19 agent: Molecular Docking, Molecular Dynamic Simulation, ADMET and DFT analysis , 2021, Letters in Drug Design & Discovery.

[16]  M. Bouachrine,et al.  DFT Studies on Molecular Structure, Absorption properties, NBO Analysis, and Hirshfeld Surface Analysis of Iron(III) Porphyrin Complex , 2021 .

[17]  G. P,et al.  Docking studies and molecular dynamics simulation of triazole benzene sulfonamide derivatives with human carbonic anhydrase IX inhibition activity , 2021, RSC advances.

[18]  R. Al-Salahi,et al.  Investigation of 4-Hydrazinobenzoic Acid Derivatives for Their Antioxidant Activity: In Vitro Screening and DFT Study , 2021, ACS omega.

[19]  S. Akter,et al.  Active site-specific quantum tunneling of hACE2 receptor to assess its complexing poses with selective bioactive compounds in co-suppressing SARS-CoV-2 influx and subsequent cardiac injury , 2021, Journal of advanced veterinary and animal research.

[20]  Z. M. Zabidi,et al.  Biological Activity Relationship of Cyclic and Noncyclic Alkanes Using Quantum Molecular Descriptors , 2021, Open Journal of Applied Sciences.

[21]  M. Cruz,et al.  Antitumor Activity of Fucus vesiculosus-Derived Phlorotannins through Activation of Apoptotic Signals in Gastric and Colorectal Tumor Cell Lines , 2021, International journal of molecular sciences.

[22]  Nicholas Y. Palermo,et al.  Targeting SARS-CoV-2 Receptor Binding Domain with Stapled Peptides: An In Silico Study , 2021, The journal of physical chemistry. B.

[23]  S. Muthu,et al.  Experimental and theoretical spectroscopic (FT-IR, FT-Raman, UV-VIS) analysis, natural bonding orbitals and molecular docking studies on 2-bromo-6-methoxynaphthalene: A potential anti-cancer drug , 2021, Heliyon.

[24]  Waqar Hussain,et al.  Biological perspective of thiazolide derivatives against Mpro and MTase of SARS-CoV-2: Molecular docking, DFT and MD simulation investigations , 2021, Chemical Physics Letters.

[25]  S. Smid,et al.  Phlorotannins: A review on biosynthesis, chemistry and bioactivity , 2021 .

[26]  R. Bauer,et al.  Natural products in drug discovery: advances and opportunities , 2021, Nature Reviews Drug Discovery.

[27]  N. Mukhopadhyay,et al.  PLK1 Induces Chromosomal Instability and Overrides Cell-Cycle Checkpoints to Drive Tumorigenesis , 2020, Cancer Research.

[28]  I. Patel,et al.  A review on phytoconstituents of marine brown algae , 2020, Future Journal of Pharmaceutical Sciences.

[29]  Hoang Linh Nguyen,et al.  Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations , 2020, The journal of physical chemistry. B.

[30]  M. Arivazhagan,et al.  Molecular structure, aromaticity, vibrational investigation and dual descriptor for chemical reactivity on 1- chloroisoquinoline using quantum chemical studies , 2020, Results in Materials.

[31]  Heba R. Hashem.  IN Silico Approach of Some Selected Honey Constituents as SARS-CoV-2 Main Protease (COVID-19) Inhibitors , 2020, Eurasian Journal of Medicine and Oncology.

[32]  Bhumi M. Shah,et al.  In silico studies on therapeutic agents for COVID-19: Drug repurposing approach , 2020, Life Sciences.

[33]  E. Baerends,et al.  The Electron Affinity as the Highest Occupied Anion Orbital Energy with a Sufficiently Accurate Approximation of the Exact Kohn–Sham Potential , 2019, Journal of chemical theory and computation.

[34]  E. Ibáñez,et al.  Comparison of Extraction Techniques and Surfactants for the Isolation of Total Polyphenols and Phlorotannins from the Brown Algae Lobophora variegata , 2019, Analytical Letters.

[35]  Moniruzzaman.  Thermodynamic, HOMO-LUMO, MEP and ADMET Studiesof Metronidazole and its Modified Derivatives Based onDFT , 2019 .

[36]  M. Saini,et al.  Specioside (SS) & verminoside (VS) (Iridoid glycosides): isolation, characterization and comparable quantum chemical studies using density functional theory (DFT) , 2019, Heliyon.

[37]  J. Venkatesan,et al.  Phlorotannins , 2018, Encyclopedia of Food Chemistry.

[38]  Ron O. Dror,et al.  Molecular Dynamics Simulation for All , 2018, Neuron.

[39]  M. Malumbres,et al.  Plk1 overexpression induces chromosomal instability and suppresses tumor development , 2018, Nature Communications.

[40]  D. Sarkar,et al.  Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against Mycobacterium tuberculosis , 2018, RSC advances.

[41]  M. Brylinski.  Aromatic interactions at the ligand–protein interface: Implications for the development of docking scoring functions , 2018, Chemical biology & drug design.

[42]  Xiaosheng Wang,et al.  PLK1, A Potential Target for Cancer Therapy , 2016, Translational oncology.

[43]  R. Praveena,et al.  DFT study of glycosyl group reactivity in quercetin derivatives , 2016 .

[44]  A. Yegdaneh,et al.  Chemical constituents and biological activities of two Iranian Cystoseira species , 2016, Research in pharmaceutical sciences.

[45]  P. Ellis,et al.  A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non-Small-Cell Lung Cancer. , 2015, Clinical Lung Cancer.

[46]  Jaebong Kim,et al.  PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis , 2015, BioMed research international.

[47]  Yaming Fan,et al.  Optimization of the microwave-assisted extraction of phlorotannins from Saccharina japonica Aresch and evaluation of the inhibitory effects of phlorotannin-containing extracts on HepG2 cancer cells , 2013, Chinese Journal of Oceanology and Limnology.

[48]  Cheng Luo,et al.  Computational drug discovery , 2012, Acta Pharmacologica Sinica.

[49]  F. Fiorentini,et al.  NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor. , 2011, Bioorganic & medicinal chemistry letters.

[50]  Freddie R Salsbury,et al.  Molecular dynamics simulations of protein dynamics and their relevance to drug discovery. , 2010, Current opinion in pharmacology.

[51]  K. Strebhardt,et al.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy , 2010, Nature Reviews Drug Discovery.

[52]  J. Choi,et al.  Molecular docking studies of phlorotannins from Eisenia bicyclis with BACE1 inhibitory activity. , 2010, Bioorganic & medicinal chemistry letters.

[53]  Hak-Ju Kim,et al.  Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent alpha-glucosidase and alpha-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice. , 2009, European journal of pharmacology.

[54]  P. Schöffski.  Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. , 2009, The oncologist.

[55]  Roman M. Balabin.  Enthalpy difference between conformations of normal alkanes: Intramolecular basis set superposition error (BSSE) in the case of n-butane and n-hexane. , 2008, The Journal of chemical physics.

[56]  Ping Yang,et al.  Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. , 2008, Mayo Clinic proceedings.

[57]  Ji Luo,et al.  Koopmans' theorem for large molecular systems within density functional theory. , 2006, The journal of physical chemistry. A.

[58]  Arash A. Mostofi,et al.  Elimination of basis set superposition error in linear-scaling density-functional calculations with local orbitals optimised in situ , 2006 .

[59]  Palanisamy Thanikaivelan,et al.  Application of quantum chemical descriptor in quantitative structure activity and structure property relationship , 2000 .

[60]  H. A. Aziz,et al.  Molecular and Electronic Structure of Some Symmetrically meso-Substituted Hg(II)-Porphyrin Complexes , 2017 .

[61]  G. Bottegoni,et al.  Polo-like kinases inhibitors. , 2012, Current medicinal chemistry.

[62]  Kil-Nam Kim,et al.  Isolation and identification of new compound, 2,7″-phloroglucinol-6,6′-bieckol from brown algae, Ecklonia cava and its antioxidant effect , 2012 .

[63]  Investigation of 4Hydrazinobenzoic Acid Derivatives for Their Antioxidant Activity: In Vitro Screening and DFT Study , 2022 .